SCHEMBL8938516

SCHEMBL8938516

CCS(=O)(=O)Nc1ccc(CCN2CCCC(OC(c3ccccc3)c3ccccc3)C2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 5/20 0.44
SLC6A3 Q01959 4/20 0.44
SLC6A4 P31645 3/20 0.44
DRD3 P35462 2/20 0.44
GRM5 P41594 1/20 0.43
GRM7 Q14831 1/20 0.43
GRM3 Q14832 1/20 0.43
CYP2D6 P10635 3/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42
PMP22 Q01453 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP3A4 P08684 2/20 0.41
CYP1A2 P05177 1/20 0.41
SIGMAR1 Q99720 2/20 0.41
CHRM2 P08172 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
CHRM1 P11229 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8938241 0.91 SLC6A2 (0.45) SLC6A2SLC6A3SLC6A4DRD3GRM5
SCHEMBL8938401 0.89 SLC6A2 (0.45) SLC6A2SLC6A3SLC6A4DRD3GRM5
SCHEMBL8938352 0.83 DRD3 (0.51) SLC6A2SLC6A3SLC6A4DRD3GRM5
SCHEMBL8938637 0.83 SIGMAR1 (0.51) SLC6A2SLC6A3SLC6A4DRD3CYP2D6
SCHEMBL8938314 0.82 SLC6A2 (0.48) SLC6A2SLC6A3SLC6A4DRD3GRM5
SCHEMBL8938328 0.81 DRD2 (0.47) SLC6A2DRD3GRM5GRM7GRM3
SCHEMBL8938185 0.80 SLC6A2 (0.50) SLC6A2SLC6A3SLC6A4GRM5GRM7
SCHEMBL8938288 0.80 SLC6A2 (0.50) SLC6A2SLC6A3SLC6A4GRM5GRM7
SCHEMBL8938477 0.80 SLC6A2 (0.51) SLC6A2SLC6A3SLC6A4DRD3GRM5
SCHEMBL8938360 0.80 SLC6A2 (0.51) SLC6A2SLC6A3SLC6A4DRD3GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5534626-A SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST INTERMEDIATES PFIZER INC. (US) 1996-07-09 US disclosed
US-5410046-A Selective muscarinic receptor antagonists PFIZER INC. (US) 1995-04-25 US disclosed
US-5231104-A Anticholinergic PFIZER INC. (US) 1993-07-27 US disclosed
EP-0350309-B1 PIPERIDINE DERIVATIVES Pfizer Limited (GB) 1992-11-11 EP disclosed
US-5089505-A Anticholinergic agents PFIZER INC. (US) 1992-02-18 US disclosed
EP-0350309-A1 Piperidine derivatives Pfizer Limited (GB) 1990-01-10 EP disclosed